- Home
- ISPC vs QNRX Comparison
ISPC vs QNRX Comparison
Compare ISPC & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPC
- QNRX
- Stock Information
- Founded
- ISPC 2009
- QNRX 2018
- Country
- ISPC United States
- QNRX United States
- Employees
- ISPC 24
- QNRX N/A
- Industry
- ISPC Precision Instruments
- QNRX Medical/Dental Instruments
- Sector
- ISPC Health Care
- QNRX Health Care
- Exchange
- ISPC Nasdaq
- QNRX Nasdaq
- Market Cap
- ISPC 5.7M
- QNRX 5.2M
- IPO Year
- ISPC 2021
- QNRX N/A
- Fundamental
- Price
- ISPC $0.54
- QNRX $18.30
- Analyst Decision
- ISPC
- QNRX
- Analyst Count
- ISPC 0
- QNRX 0
- Target Price
- ISPC N/A
- QNRX N/A
- AVG Volume (30 Days)
- ISPC 216.8K
- QNRX 1.0M
- Earning Date
- ISPC 11-17-2025
- QNRX 11-06-2025
- Dividend Yield
- ISPC N/A
- QNRX N/A
- EPS Growth
- ISPC N/A
- QNRX N/A
- EPS
- ISPC N/A
- QNRX N/A
- Revenue
- ISPC $3,352,744.00
- QNRX N/A
- Revenue This Year
- ISPC $35.93
- QNRX N/A
- Revenue Next Year
- ISPC N/A
- QNRX N/A
- P/E Ratio
- ISPC N/A
- QNRX N/A
- Revenue Growth
- ISPC N/A
- QNRX N/A
- 52 Week Low
- ISPC $0.53
- QNRX $5.01
- 52 Week High
- ISPC $4.90
- QNRX $48.30
- Technical
- Relative Strength Index (RSI)
- ISPC 31.72
- QNRX 71.06
- Support Level
- ISPC $0.56
- QNRX $8.05
- Resistance Level
- ISPC $0.67
- QNRX $14.03
- Average True Range (ATR)
- ISPC 0.06
- QNRX 2.15
- MACD
- ISPC 0.00
- QNRX 0.74
- Stochastic Oscillator
- ISPC 16.94
- QNRX 99.47
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.